Vasculitis & polymyalgia rheumatica

Myocardial infarction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis: a population-based cohort study

RMD OpenPublished Population-based cohort study

Main finding · First MIResult — go to the resultIncidence rate ratio 1.9 95% CI 1.3–2.8

Authors' conclusion

The MI IR is greater in individuals diagnosed with AAV compared with background population, especially those with more severe disease, and highest in the 3 months following diagnosis. Age at diagnosis is the single independent predictor of MI in AAV in this study.

Study context

Population
Patients diagnosed with AAV 1997–2016 in Skåne, Sweden325 AAV patients included
Participants
282 vs 2,763
Exposure
AAV vs age- and sex-matched reference subjects from the background population
  • AAVn = 282
  • Referencen = 2,763reference
Outcome
IR of first MI after AAV diagnosis and IRR of MI in AAV vs background population
Methodological detailsage-matched and sex-matched reference subjects (10 per patient), Cox regression
  • Age-matched and sex-matched reference subjects (10 per patient)
  • Cox regression

Main finding

First MI

Incidence rate ratio

1.9

95% CI 1.3–2.8

Events by group

AAV

11%

37

AAVvs Reference
IRR 1.9 (95% CI 1.3–2.8)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeIRR (95% CI)
MI in MPO-ANCA+ disease (subgroup)2.5 (1.5–4.3)
MI in high disease activity at diagnosis (subgroup)2.1 (1.3–3.3)
Myocardial infarction (MI) incidence rate (IR) in the 3 months following AAV diagnosis
11.8/100 person-years · 95% CI 6.2–22.7

Predictors of MI (Cox regression)

Age at AAV diagnosis independently predicted MI

Original publication

Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study. RMD Open. Published 17 April 2025. doi:10.1136/rmdopen-2024-005055

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.